fbpx
  • Home
  • Study Details
Open

Genetic Determinants of Neurological and Developmental Disorders

The purpose of this study is to identify and genomically-characterize individuals with genetically unexplained neurodevelopmental disorders. The overarching goal is to provide patients with improved information about the underlying genetic basis of their disorder and illuminate novel genetically-defined treatment approaches in the future.

Age & Gender

  • 0 days ~ 99 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)

Location

What will be asked of you

The participant will be asked to provide a blood sample at the study visit.

In-person visits:
1
Phone or online visits:
1
Total length of participation:
1 study visit

Looking for Healthy Volunteers

Requirements for healthy volunteers are different than for those with a specific condition. If you are interested in becoming a healthy volunteer for this study, use the below categories to determine if you are able to participate.

Able to participate:

  • Genetically unexplained neurodevelopmental disorder
  • Genetically unexplained developmental disorder

Not eligible if:

  • Do not have genetically unexplained neurological disorder
  • Do not have genetically unexplained developmental disorder

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

UNC Medical Center
101 Manning Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Senyene Hunter
Neurology

Study Type

Clinical or Medical
Observational

Study Topics

Developmental
Genetics and Genetic Disorders
Rare Diseases

IRB Number

20-3103

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.